Form 8-K ImmunoGen, Inc. For: Dec 17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Immunogen Inc. (IMGN) PT Raised to $4 at SVB Leerink
December 17, 2019 11:15 AM ESTSVB Leerink analyst Jonathan Chang raised the price target on Immunogen Inc. (NASDAQ: IMGN) to $4.00 (from $2.00) while maintaining a Market Perform rating.
SORAYA opens door for accelerated approval; top-line data in mid-2021.... More
